,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['paradigm', 'breast', 'enhertu', 'astrazeneca']
asco: astrazeneca's enhertu is poised to change the breast cancer paradigm 
Tokyo-based Editor-in-Chief, Asia-Pacific, for @PharmaScrip @PharmaPinkSheet, @Pharma_Intell. All views my own, RTs not endorsements.